MedTrace Logo

TeleCare North Diabetes

NCT06134934 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-01

No results posted yet for this study

Summary

This feasibility study will evaluate the feasibility of two telemonitoring designs for non-insulin treated T2D patients with an eye to identify the most suitable telemonitoring intervention for a future large-scale randomized trial.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Telemonitoring 1

This telemonitoring intervention design include self-monitoring of blood glucose (SMBG) together with monitoring of sleep, mental health, blood pressure and activity.

OTHER

Telemonitoring 2

This telemonitoring intervention design include self-monitoring of blood glucose (SMBG) together with monitoring of sleep and mental health.

Sponsors & Collaborators

  • Steno Diabetes Center Nordjylland

    collaborator OTHER

  • Aalborg University

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Peter Vestergaard, PhD (and MD) · Aalborg University Hospital and Steno Diabetes Center North Denmark

  • Sisse H Laursen, PhD · Aalborg University and Aalborg University Hospital

  • Stine Hangaard, PhD · Aalborg University and Steno Diabetes Center North Denmark

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-09
Primary Completion
2025-05-01
Completion
2026-05-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06134934 on ClinicalTrials.gov